These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 11880187

  • 1. Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenografts.
    Harris SR, Schoeffner DJ, Yoshiji H, Thorgeirsson UP.
    Cancer Lett; 2002 May 08; 179(1):95-101. PubMed ID: 11880187
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.
    Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK.
    Proc Natl Acad Sci U S A; 2001 Feb 27; 98(5):2604-9. PubMed ID: 11226286
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells.
    Yoshiji H, Harris SR, Thorgeirsson UP.
    Cancer Res; 1997 Sep 15; 57(18):3924-8. PubMed ID: 9307273
    [Abstract] [Full Text] [Related]

  • 8. Induction of angiogenesis by expression of soluble type II transforming growth factor-beta receptor in mouse hepatoma.
    Kim KY, Jeong SY, Won J, Ryu PD, Nam MJ.
    J Biol Chem; 2001 Oct 19; 276(42):38781-6. PubMed ID: 11457844
    [Abstract] [Full Text] [Related]

  • 9. VEGF modulates NO production: the basis of a cytoprotective effect?
    Servos S, Zachary I, Martin JF.
    Cardiovasc Res; 1999 Mar 19; 41(3):509-10. PubMed ID: 10435021
    [No Abstract] [Full Text] [Related]

  • 10. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
    Ludwig HC, Feiz-Erfan I, Bockermann V, Behnke-Mursch J, Schallock K, Markakis E.
    Anticancer Res; 2000 Mar 19; 20(1A):299-304. PubMed ID: 10769671
    [Abstract] [Full Text] [Related]

  • 11. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Tosatti MP, Presta M.
    Am J Pathol; 2003 Jun 19; 162(6):1913-26. PubMed ID: 12759248
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells.
    Yoshiji H, Kuriyama S, Yoshii J, Yamazaki M, Kikukawa M, Tsujinoue H, Nakatani T, Fukui H.
    Hepatology; 1998 Dec 19; 28(6):1489-96. PubMed ID: 9828211
    [Abstract] [Full Text] [Related]

  • 13. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Nakatani T, Tsujinoue H, Fukui H.
    Hepatology; 1999 Nov 19; 30(5):1179-86. PubMed ID: 10534339
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
    Zhang HT, Craft P, Scott PA, Ziche M, Weich HA, Harris AL, Bicknell R.
    J Natl Cancer Inst; 1995 Feb 01; 87(3):213-9. PubMed ID: 7535859
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
    Józkowicz A, Pankiewicz J, Dulak J, Partyka L, Wybrańska I, Huk I, Dembińska-Kieć A.
    Acta Biochim Pol; 1999 Feb 01; 46(3):703-15. PubMed ID: 10698278
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide.
    Scalia R, Booth G, Lefer DJ.
    FASEB J; 1999 Jun 01; 13(9):1039-46. PubMed ID: 10336886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.